Ftse Mib
36.049,36
-0,26%
DAX
21.042,00
0,18%
S&P 500
6.043,34
0,78%
NASDAQ
19.740,34
0,56%
Bitcoin
107.139,74
5,01%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Geron Corp (GERN) Geron Corp (GERN) Notizie

Geron Corp

GERN
2,9799
0,0899 (3,11%)
Ultimo aggiornamento: 20:43:17
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/1/202514:05EDGAR2Form 8-K - Current report
10/1/202522:05EDGAR2Form S-8 - Securities to be offered to employees in employee..
02/1/202522:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202422:30BWGeron Reports Inducement Grants Under Nasdaq Listing Rule..
13/12/202412:36BWGeron Announces Positive CHMP Opinion for RYTELO™..
10/12/202415:00BWGeron Announces Phase 1 Findings from Two-Part IMproveMF..
27/11/202415:00BWGeron to Participate in the 7th Annual Evercore ISI..
21/11/202422:30BWGeron Reports Inducement Grants Under Nasdaq Listing Rule..
14/11/202415:31EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202412:25EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
11/11/202422:30BWGeron Corporation Announces Appointment of Joseph Eid, M.D...
11/11/202415:00BWGeron to Participate in the Stifel 2024 Healthcare..
07/11/202413:10GLOBERoyalty Pharma to Acquire Royalty Interest in Geron’s RYTELO..
07/11/202413:01BWGeron Corporation Announces Up to $375 Million in Funding..
07/11/202413:00BWGeron Corporation Reports Third Quarter 2024 Financial..
05/11/202415:00BWGeron Announces New Data to be Presented at Upcoming ASH..
17/10/202422:30BWGeron Reports Inducement Grants Under Nasdaq Listing Rule..
15/10/202422:30BWGeron to Announce Third Quarter 2024 Financial Results on..
19/9/202422:30BWGeron Reports Inducement Grants Under Nasdaq Listing Rule..
09/9/202422:35EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/9/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/9/202422:15BWGeron Corporation Announces Appointment of Jim Ziegler as..
22/8/202422:30BWGeron Reports Inducement Grants Under Nasdaq Listing Rule..
08/8/202413:00BWGeron Corporation Reports Second Quarter 2024 Financial..
26/7/202413:30BWGeron Announces Updated NCCN Guidelines® Recommending..
23/7/202422:15BWGeron Corporation Announces Chief Commercial Officer to..
18/7/202422:30BWGeron to Announce Second Quarter 2024 Financial Results on..
10/7/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/7/202421:44EDGAR2Form 144 - Report of proposed sale of securities
20/6/202422:30BWGeron Reports Inducement Grants Under Nasdaq Listing Rule..
12/6/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202423:53EDGAR2Form 144 - Report of proposed sale of securities
10/6/202418:30EDGAR2Form 144 - Report of proposed sale of securities
07/6/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:03EDGAR2Form 8-K - Current report
07/6/202403:58BWGeron Announces FDA Approval of RYTELO™ (imetelstat), a..
05/6/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202423:02EDGAR2Form 144 - Report of proposed sale of securities
17/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202422:30BWGeron Reports Inducement Grants Under Nasdaq Listing Rule..
15/5/202422:07EDGAR2Form 144 - Report of proposed sale of securities
13/5/202422:05EDGAR2Form 8-K - Current report
02/5/202413:00BWGeron Corporation Reports First Quarter 2024 Financial..
25/4/202422:30BWGeron to Announce First Quarter 2024 Financial Results on..
18/4/202422:30BWGeron Reports Inducement Grants Under Nasdaq Listing Rule..
03/4/202422:30BWGeron to Participate at Upcoming Investor Conferences in..
Apertura: 2,95 Min: 2,895 Max: 3,00
Chiusura: 2,89

La tua Cronologia

NASDAQ
GERN
Geron
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network